TVTX

TRAVERE THERAPEUTICS INC

TVTX·89422G107·US·Common Stock·Healthcare - Biotechnology-13D/G

TVTX (TRAVERE THERAPEUTICS INC) is held by 150 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($339.2M), FMR LLC ($325.9M), BlackRock, Inc. ($231.5M). Net institutional sentiment: Mixed.

150
Holders
Avg rating(34 Elite)
$2.3B
Total Value
53% (167)
Fund Consensus
84 buying - 76 selling
TVTXSmart Money Verdict
View all
Held by 150 funds
34 elite
Who's Trading
InsiderCTCoughlin TimothySell $141KMay 15, 2026
ActivistARArmistice Capital, LLC5.3%May 15, 2026
InsiderDMDube Eric MSell $989KMay 6, 2026
InsiderCRCline Christopher R.Sell $14KMay 6, 2026
InsiderREROTE WILLIAM E.Sell $121KMay 6, 2026
InsiderIJInrig JulaSell $14KMay 6, 2026
InsiderREREED ELIZABETH ESell $91KMay 6, 2026
InsiderHPHeerma PeterSell $101KMay 5, 2026
InsiderCRCline Christopher R.Sell $102KMay 5, 2026
ActivistVAVanguard Capital Management5.1%Apr 30, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
11.4M(+8.6%)$339.2M0.2%+196.37%
40
Increased
11M(+14.0%)$325.9M0.0%+75.37%
35
Decreased
7.8M(-1.0%)$231.5M0.0%+225.80%
0
Increased
5M(+4.3%)$147.4M0.0%+182.31%
32
New
4M$120.2M0.0%+100.18%
42
Decreased
3.3M(-13.3%)$97.2M0.2%+50.19%
0
Increased
2.4M(+10.6%)$70.4M0.0%+156.93%
33
Decreased
2M(-12.5%)$58.4M0.1%+159.48%
0
Decreased
1.7M(-8.0%)$51.1M0.0%+145.75%
0
New
1.7M$50.8M0.0%+100.18%
41
Increased
1.5M(+30.4%)$44.8M0.0%+170.29%
37
Decreased
1.3M(-27.3%)$40M0.0%+163.41%
0
Increased
1.3M(+42.3%)$38.1M0.3%+106.84%
47
Increased
1M(+27.9%)$30.4M0.0%+128.11%
36
Decreased
977,000(-66.6%)$29M0.0%+203.26%
0
Decreased
938,569(-5.5%)$27.9M0.0%+187.55%
0
Increased
925,919(+5.0%)$27.5M0.0%+179.53%
30
Increased
900,868(+3.1%)$26.8M0.1%+51.31%
30
Increased
856,757(+102.7%)$25.5M0.0%+159.15%
46
Decreased
836,544(-23.6%)$24.9M0.0%+131.35%
0

Showing 1-20 of 167

1 / 9

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used